Wang Shizhi, Li Yuqiu, Yang Qijun, Zhang Xue, Cheng Yunqi, Li Zimeng, Wang Jingyi, Zeng Qingfu
Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Queen Mary College of Nanchang University, Nanchang, China.
Front Med (Lausanne). 2022 Mar 2;9:770967. doi: 10.3389/fmed.2022.770967. eCollection 2022.
Primary tumor of the inferior vena cava is a rare tumor, which arises from the smooth muscle of vascular walls. Surgery appears the only curative treatment. However, the optimal surgical methods and surgical management are not well-studied. In this article, we reviewed the successful treatment experience of patients in our center who had resection of primary tumor of the inferior vena cava and reviewed the relevant literature.
Four cases of patients who undergoing initial resection of primary tumors of the inferior vena cava from September 2017 to August 2021 in the Second Affiliated Hospital of Nanchang University were screened and followed up. They were discussed and cases reported in this field were reviewed.
Among the four patients, three of them were female. The median age of the disease is 53.75 years (range 45-60 years). After surgical treatment, tumors were removed in all patients, and some patients had reconstruction of inferior vena cava. There were no disease-specific deaths, no serious complications, and no recurrence during follow-up in these cases.
Careful preoperative examination, correct surgical treatment methods, and multidisciplinary collaboration can lead to safe and successful operations, which improve the survival rate of patients.
下腔静脉原发性肿瘤是一种罕见肿瘤,起源于血管壁的平滑肌。手术似乎是唯一的治愈性治疗方法。然而,最佳手术方法和手术管理尚未得到充分研究。在本文中,我们回顾了本中心行下腔静脉原发性肿瘤切除术患者的成功治疗经验,并复习了相关文献。
筛选2017年9月至2021年8月在南昌大学第二附属医院首次行下腔静脉原发性肿瘤切除术的4例患者并进行随访。对他们进行了讨论,并复习了该领域报道的病例。
4例患者中,3例为女性。疾病的中位年龄为53.75岁(范围45 - 60岁)。手术治疗后,所有患者的肿瘤均被切除,部分患者进行了下腔静脉重建。这些病例在随访期间无疾病特异性死亡、无严重并发症且无复发。
仔细的术前检查、正确的手术治疗方法以及多学科协作可实现安全且成功的手术,从而提高患者的生存率。